Previous Article | Next Article 
Journal of Virology, September 2008, p. 9303, Vol. 82, No. 18
0022-538X/08/$08.00+0 doi:10.1128/JVI.01231-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Not So Fast on Recombination Analysis of Newcastle Disease Virus

LETTER
Regarding the letter of Han et al. published earlier in the
Journal of Virology (
3) indicating that "powerful evidence"
of recombination is a call for caution in the use of Newcastle
disease virus (NDV)-based vaccines, I would like to suggest
that the evidence for recombination is still weak. The authors
cite three reports that suggest the existence of recombination,
but a closer look reveals the possibility of oversight in the
interpretation of the data (
1,
2,
5). There is evidence of recombination
in the existing GenBank NDV sequences, but unfortunately, the
vast majority of these available NDV sequences have been obtained
by PCR amplification of RNAs from crude field samples grown
in eggs. The possibility of reporting artificial recombination
caused by polymerase template switching in these samples or
by laboratory-generated recombinants needs to be considered.
The widespread use of live vaccines in poultry and the extensive
presence of nonvirulent endemic NDVs in live bird markets and
in wildlife (
4) make the existence of unnoticed mixed infections
in field samples likely. In the particular case of the three
publications cited, the Chare et al. and Han et al. results
are based on the analysis of GenBank sequences that were obtained
without any purification. In the Qin et al. paper, three plaque
purification steps were performed, but no attempts were made
to confirm the absence of contaminant viruses in the original
samples or to investigate the possibility of contamination with
PCR products, which normally abound in NDV sequencing laboratories.
In fact, despite the availability of a large number of NDV sequences
in GenBank databases, no NDV report exists that describes the
generation of a natural progeny of viruses derived from a recombination
event. Although I agree with the authors in the need for caution
in the use of live NDV vectored vaccines, caution in the interpretation
of the data is also needed.

FOOTNOTES
Ed. note: There is no reply to this letter.

REFERENCES
1 - Chare, E. R., E. A. Gould, and E. C. Holmes. 2003. Phylogenetic analysis reveals a low rate of homologous recombination in negative-sense RNA viruses. J. Gen. Virol. 84:2691-2703.[Abstract/Free Full Text]
2 - Han, G. Z., C. Q. He, N. Z. Ding, and L. Y. Ma. 2008. Identification of a natural multi-recombinant of Newcastle disease virus. Virology 371:54-60.[CrossRef][Medline]
3 - Han, G. Z., X. P. Liu, and S. S. Li. 2008. Caution about Newcastle disease virus-based live attenuated vaccine. J. Virol. 82:6782.[Free Full Text]
4 - Kim, L. M., D. J. King, P. E. Curry, D. L. Suarez, D. E. Swayne, D. E. Stallknecht, R. D. Slemons, J. C. Pedersen, D. A. Senne, K. Winker, and C. L. Afonso. 2007. Phylogenetic diversity among low-virulence Newcastle disease viruses from waterfowl and shorebirds and comparison of genotype distributions to those of poultry-origin isolates. J. Virol. 81:12641-12653.[Abstract/Free Full Text]
5 - Qin, Z., L. Sun, B. Ma, Z. Cui, Y. Zhu, Y. Kitamura, and W. Liu. 2008. F gene recombination between genotype II and VII Newcastle disease virus. Virus Res. 131:299-303.[CrossRef][Medline]
| | | | | |
Claudio L. Afonso*
SEPRL ARS-USDA, SAA 934 College Station Road Athens, Georgia 30605
|
| | | | | |
* Phone: (706) 546-3642 Fax: (706) 546-3161 E-mail: claudio.afonso{at}ars.usda.gov |
Journal of Virology, September 2008, p. 9303, Vol. 82, No. 18
0022-538X/08/$08.00+0 doi:10.1128/JVI.01231-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.